Correlation Between Palisade Bio and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Candel Therapeutics, you can compare the effects of market volatilities on Palisade Bio and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Candel Therapeutics.
Diversification Opportunities for Palisade Bio and Candel Therapeutics
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Palisade and Candel is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Palisade Bio i.e., Palisade Bio and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Palisade Bio and Candel Therapeutics
Given the investment horizon of 90 days Palisade Bio is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Palisade Bio is 1.1 times less risky than Candel Therapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 715.00 in Candel Therapeutics on September 5, 2024 and sell it today you would lose (264.00) from holding Candel Therapeutics or give up 36.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Palisade Bio vs. Candel Therapeutics
Performance |
| Timeline |
| Palisade Bio |
| Candel Therapeutics |
Palisade Bio and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Palisade Bio and Candel Therapeutics
The main advantage of trading using opposite Palisade Bio and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Palisade Bio vs. Candel Therapeutics | Palisade Bio vs. Cingulate Warrants | Palisade Bio vs. Unicycive Therapeutics | Palisade Bio vs. Cardio Diagnostics Holdings |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |